Improved disease markers suggest dual response in a patient with metastatic castration resistant prostate cancer and chronic lymphocytic leukemia following active cellular immunotherapy
Crossref DOI link: https://doi.org/10.1186/S13045-015-0149-X
Published Online: 2015-05-14
Published Print: 2015-12
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Cheng, Heather H.
Soleau, Colleen
Yu, Evan Y.
License valid from 2015-05-14
Article History
Received: 22 April 2015
Accepted: 6 May 2015
First Online: 14 May 2015